Autobio Diagnostics Gets 18 Medical Device Registrations in Henan

Autobio Diagnostics Gets 18 Medical Device Registrations in Henan

Autobio Diagnostics' Unit Renews Medical Device, Drug Licenses

Autobio Diagnostics' Unit Renews Medical Device, Drug Licenses

Autobio Diagnostics, Subsidiary, Gets Registration Certificates for Four Medical Devices

(MT Newswires) -- Autobio Diagnostics (SHA:603658) and its subsidiary, Autobio Laboratory Instruments (Zhengzhou), received medical device registration certificates from regulators for four medical devices, according to a Shanghai bourse disclosure on Tuesday. The five-year certificates are for the aspergillus galactomannan antigen detection kit (magnetic particle chemiluminescence method), aspergillus IgG antibody detection kit (magnetic particle chemiluminescence method), inhibin A detection kit (magnetic particle chemiluminescence method), and fully automatic microbial culture monitoring system (models: AutoBes X, AutoBes X-R), the Chinese medical reagent manufacturer said.

Autobio: Net profit in the first half of 2025 is 571 million yuan, a year-on-year decrease of 7.83%

Autobio announced that its operating revenue in the first half of 2025 was 2.06 billion yuan, a year-on-year decrease of 6.65%. Net profit was 571 million yuan, a year-on-year decrease of 7.83%

Autobio: Net profit of RMB 571 million in the first half of the year